CTC (Chicago Trading Company)
NVAX icon

CTC (Chicago Trading Company)’s Novavax NVAX Stock Holding History

CTC (Chicago Trading Company)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11
Closed -$570 – 302
2022
Q1 		$808 Sell
11
-124
-92% -$11.1K ﹤0.01% 288
2021
Q4 		$19.3K Sell
135
-44
-25% -$7.56K 0.01% 165
2021
Q3 		$37.1K Buy
+179
New +$39.5K 0.02% 96

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

CTC (Chicago Trading Company)'s NVAX Position: Q2 2022 in Review

CTC (Chicago Trading Company) sold out of Novavax (NVAX) in Q2 2022, closing a stake of 11 shares — an estimated $570 sold.

CTC (Chicago Trading Company) first reported a position in NVAX in Q3 2021 and held it in 3 quarters. The position peaked at $37.1K in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • CTC (Chicago Trading Company) reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 11 Novavax shares in Q2 2022, an estimated $570.
  • CTC (Chicago Trading Company) first reported a position in Novavax in Q3 2021 and held it in 3 quarters.
  • CTC (Chicago Trading Company)'s Novavax position peaked at $37.1K in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on CTC (Chicago Trading Company)'s 13F filing for Q2 2022, filed 7 Jul 2022.